Patent Assignment
Reel/Frame 069273/0237
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 55010 Frame: 654. Assignor(S) Hereby Confirms the Release of Security Interest .
Recorded: 2024-10-29
Pages: 14
Assignor
KREOS CAPITAL V (UK) LIMITED
Executed: 2020-12-15
Assignee
MEREP BIOPHARMA 1 LIMITED
1 CAVENDISH PLACE, 4TH FLOOR, LONDON, W1G 0QF, UNITED KINGDOM
Covered Property
(1)
Use of a Pyrazole Derivative in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Change of Address
May 23, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 046223/0457 →
Security Interest
Nov 7, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0556 →
Release of Security Interest
Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMINTED
Reel/Frame 055010/0654 →
Corrective Assignment to Correct the Spelling of the Receiving Party Data from Merep Biopharma I Limited to Mereo Biopharma 1 Limited Previously Recorded on Reel 69273 Frame 237. Assignor(S) Hereby Confirms the Corrective Assignment.
Apr 10, 2025
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 070808/0578 →